Numerous domestic new material enterprises are strengthening industry-university-research collaboration with universities and R&D institutions, focusing on the development and technological iteration of new processes for novel material intermediates and pharmaceutical intermediates. Through joint efforts, a batch of high-value-added, low-cost, and low-pollution new technologies have achieved industrialization, effectively meeting the demand for high-quality intermediates in downstream pharmaceutical and new material sectors.